<DOC>
	<DOCNO>NCT01376557</DOCNO>
	<brief_summary>This study intend assess effect HbA1c different dose regimen LX4211 combination metformin subject Type 2 Diabetes Mellitus inadequate glycemic control metformin monotherapy .</brief_summary>
	<brief_title>Safety Efficacy LX4211 With Metformin Type 2 Diabetes Patients With Inadequate Glycemic Control Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Adult subject age 18 75 year , inclusive Confirmed diagnosis Type 2 diabetes mellitus Meet require laboratory value screen , include fast plasma glucose le 270 mg/dL Stable dose metformin monotherapy great 1500 mg/day least 8 week Willing able provide write informed consent Willing able maintain consistent dietary , physical activity , sleep pattern throughout study History Type 1 diabetes mellitus , diabetic ketoacidosis , hyperosmolar nonketotic syndrome , diabetes result pancreatic disorder secondary diabetes History renal disease clinically significant abnormal kidney function test Presence active hepatic disease clinically significant abnormal liver function test Subjects history heart attack , severe/unstable angina , coronary revascularization procedure within 6 month prior study Day 1 History clinically significant cardiac arrhythmia within one year study Day 1 Subjects congestive heart failure Subjects uncontrolled Stage III hypertension Triglycerides &gt; 1000 mg/dL Screening Known history HIV hepatitis C History illicit drug alcohol abuse one year study Day 1 Have 2 emergency room visit , doctor visit , hospitalization due hypoglycemia within 6 month study Day 1 Use investigational drug within 30 day study Day 1 Prior exposure LX4211 Use medication herbal supplement purpose weight loss Chronic use antidiabetic therapy metformin 3 month prior study Day 1 Use corticosteroid within 2 week prior study Day 1 Major surgery within 6 month study Day 1 Subjects history severe gastroparesis Inability difficulty swallow whole capsule tablet Women pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>diabetes mellitus</keyword>
</DOC>